ArticleSurgical neurology international2024
The clinical spectrum and management outcome of adult-onset aqueductal stenosis: Insight from South-West Nigeria.
Article in Surgical neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adult-onset aqueductal stenosis (AOAS) is an uncommon cause of hydrocephalus in adults. Its etiopathogenesis is poorly understood, with various proposed mechanisms, spectrum of presentation, and management. Very little has been reported on this anomaly in African literature. This study aimed to describe the pattern of presentation, clinical spectrum, and early outcomes following the shunt procedure in our population practice setting. Methods: This was a retrospective case series of patients with non-tumoral AOAS managed between 2008 and 2023 in a tertiary center in South-West Nigeria. Relevant demographic, clinical-radiologic, and outcome data were retrieved and analyzed. Results: There were seven males and one female. Their age ranged from 18 to 50 years. The duration of symptoms ranged from 3 to 120 months. All patients admitted having headaches; however, visual deterioration ( Conclusion: AOAS is an infrequent cause of hydrocephalus in our setting, with most patients seeking medical consultation following visual deterioration. Proper evaluation of adults with long-standing headaches and associated features is advocated to avert total visual loss in this subgroup. VPS insertion is a viable treatment option with a good outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.